{
    "hands_on_practices": [
        {
            "introduction": "Before running a neutralization assay, it is critical to understand the theoretical parameters that govern its performance. This practice delves into a foundational model of viral infection, where the number of viruses infecting a cell follows a Poisson distribution, to explore how the Multiplicity of Infection (MOI) impacts the assay's dynamic range. By working through this thought experiment , you will develop a crucial intuition for why high MOI can cause signal saturation and mask the true efficacy of a neutralizing antibody, a key consideration for robust assay design.",
            "id": "5091378",
            "problem": "A laboratory performs a neutralization assay in which a reporter-expressing virus is incubated with a monoclonal antibody and then used to infect a cell monolayer. The readout is the fraction of cells that become infected after a single round of infection. The assay is designed such that the number of infectious virions attaching/entering any given cell is an independent random variable, and the multiplicity of infection (MOI) is controlled by the inoculum. The multiplicity of infection (MOI) is defined as the average number of infectious virions delivered per target cell and is denoted by $\\mu$. Assume independent virion entry events with no cooperativity, such that the number of virions infecting a given cell is well approximated by a Poisson distribution with mean $\\mu$. Let $p$ denote the probability that any given virion is rendered non-infectious by the antibody during the incubation step, and assume that neutralization acts independently on each virion and that surviving virions retain full infectivity.\n\nDefine the percent neutralization $N$ as $100$ times one minus the ratio of the infected fraction with antibody to the infected fraction without antibody, using the same $\\mu$ in both conditions. From first principles, starting with the Poisson model of infection and the independence of neutralization events, derive the expected functional dependence of $N$ on $\\mu$ and $p$, and analyze how varying $\\mu$ affects the dynamic range and interpretability of $N$ across the full span $p \\in [0, 1]$. In your analysis, explicitly consider the limiting regimes $\\mu \\to 0$ and $\\mu \\to \\infty$, and compute the expected $N$ for $p = 0.5$ at $\\mu = 0.1$, $\\mu = 1$, and $\\mu = 10$.\n\nWhich option best captures the quantitative dependence of percent neutralization on $\\mu$ and the resulting implications for dynamic range and interpretability?\n\nA. Under the independent-action Poisson model, the infected fraction without antibody is $1 - e^{-\\mu}$ and with antibody is $1 - e^{-\\mu(1 - p)}$, giving $N = 100 \\left( 1 - \\frac{1 - e^{-\\mu(1 - p)}}{1 - e^{-\\mu}} \\right)$. In the low-$\\mu$ limit, $N \\approx 100 p$. As $\\mu$ increases, sensitivity collapses; for $p = 0.5$, $N$ is approximately $49\\%$ at $\\mu = 0.1$, $38\\%$ at $\\mu = 1$, and $0.67\\%$ at $\\mu = 10$. Therefore, dynamic range and interpretability are maximized at low-to-moderate $\\mu$, not at very high $\\mu$.\n\nB. Percent neutralization equals $100 p$ for all $\\mu$ because neutralization rescales the infection rate linearly, so dynamic range is independent of $\\mu$.\n\nC. Increasing $\\mu$ monotonically increases the sensitivity of percent neutralization to changes in $p$ (i.e., increases $\\frac{dN}{dp}$), because more infection events per cell provide a stronger signal, expanding dynamic range.\n\nD. In the high-$\\mu$ limit, percent neutralization approaches $100 p$ since the denominator approaches $1$, thus large $\\mu$ expands dynamic range and simplifies interpretability.",
            "solution": "We begin by deriving the functional form of the percent neutralization, $N$, from first principles.\n\nLet $k$ be the number of virions infecting a single cell. The problem states that $k$ follows a Poisson distribution with mean $\\mu$, the multiplicity of infection (MOI). The probability mass function is $P(k; \\mu) = \\frac{e^{-\\mu}\\mu^k}{k!}$.\n\nA cell is considered infected if it is infected by one or more virions, i.e., $k \\geq 1$. It is easier to calculate the probability of the complementary event: a cell is *not* infected, which corresponds to $k=0$.\n$$ P(k=0; \\mu) = \\frac{e^{-\\mu}\\mu^0}{0!} = e^{-\\mu} $$\nThe fraction of infected cells, denoted by $I$, is the probability that a cell is infected by at least one virion:\n$$ I = P(k \\geq 1; \\mu) = 1 - P(k=0; \\mu) = 1 - e^{-\\mu} $$\n\nFirst, consider the case without antibody. The fraction of infected cells, $I_{no-ab}$, is directly given by the above formula with the specified MOI, $\\mu$:\n$$ I_{no-ab} = 1 - e^{-\\mu} $$\n\nNext, consider the case with antibody. The antibody renders any given virion non-infectious with probability $p$. This means a virion remains infectious with probability $(1-p)$. Since neutralization acts independently on each virion, the effect on the overall population of virions is to reduce the average number of infectious virions per cell. The new, effective MOI, which we denote as $\\mu'$, is the original MOI scaled by the probability of a virion surviving neutralization:\n$$ \\mu' = \\mu (1-p) $$\nThe fraction of infected cells in the presence of the antibody, $I_{ab}$, is therefore given by the same infection formula but using the effective MOI, $\\mu'$:\n$$ I_{ab} = 1 - e^{-\\mu'} = 1 - e^{-\\mu(1-p)} $$\n\nThe percent neutralization $N$ is defined as $100$ times one minus the ratio of the infected fraction with antibody to the infected fraction without antibody:\n$$ N = 100 \\left( 1 - \\frac{I_{ab}}{I_{no-ab}} \\right) $$\nSubstituting our derived expressions for $I_{ab}$ and $I_{no-ab}$:\n$$ N(\\mu, p) = 100 \\left( 1 - \\frac{1 - e^{-\\mu(1-p)}}{1 - e^{-\\mu}} \\right) $$\nThis is the expected functional dependence of $N$ on $\\mu$ and $p$.\n\nNow, we analyze the behavior of $N$ in limiting regimes of $\\mu$.\n\nLimit for low MOI ($\\mu \\to 0$):\nFor small $x$, the Taylor expansion of $e^{-x}$ is $e^{-x} \\approx 1 - x$. Applying this to the numerator and denominator of the fraction within the formula for $N$:\n$$ 1 - e^{-\\mu(1-p)} \\approx 1 - (1 - \\mu(1-p)) = \\mu(1-p) $$\n$$ 1 - e^{-\\mu} \\approx 1 - (1 - \\mu) = \\mu $$\nSubstituting these approximations into the expression for $N$:\n$$ N \\approx 100 \\left( 1 - \\frac{\\mu(1-p)}{\\mu} \\right) = 100 \\left( 1 - (1-p) \\right) = 100p $$\nIn the low-$\\mu$ limit, the measured percent neutralization $N$ becomes a direct, linear measure of the underlying probability of virion neutralization $p$. This provides a full dynamic range ($p \\in [0, 1] \\implies N \\in [0, 100]$) and straightforward interpretability.\n\nLimit for high MOI ($\\mu \\to \\infty$):\nAs $\\mu \\to \\infty$, $e^{-\\mu} \\to 0$. Therefore, the denominator $1 - e^{-\\mu} \\to 1$.\nFor the numerator, if $p < 1$, then $(1-p) > 0$, and the exponent $-\\mu(1-p) \\to -\\infty$. Thus, $e^{-\\mu(1-p)} \\to 0$, and the numerator $1 - e^{-\\mu(1-p)} \\to 1$.\nThe ratio inside the parentheses approaches $\\frac{1}{1} = 1$.\n$$ N \\to 100 (1 - 1) = 0 \\quad (\\text{for } p < 1) $$\nIn the high-$\\mu$ limit, nearly all cells are infected regardless of the presence of a partially neutralizing antibody. The readout $N$ approaches $0$, meaning the assay loses its ability to distinguish different levels of neutralization (e.g., $p=0.5$ vs $p=0.9$). The dynamic range collapses.\n\nFinally, we compute the expected $N$ for $p = 0.5$ at $\\mu = 0.1$, $\\mu = 1$, and $\\mu = 10$.\nThe formula is $N = 100 \\left( 1 - \\frac{1 - e^{-0.5\\mu}}{1 - e^{-\\mu}} \\right)$.\n\nFor $\\mu = 0.1$:\n$N = 100 \\left( 1 - \\frac{1 - e^{-0.05}}{1 - e^{-0.1}} \\right) = 100 \\left( 1 - \\frac{1 - 0.951229}{1 - 0.904837} \\right) = 100 \\left( 1 - \\frac{0.048771}{0.095163} \\right) \\approx 100(1 - 0.5125) = 48.75\\%$.\n\nFor $\\mu = 1$:\n$N = 100 \\left( 1 - \\frac{1 - e^{-0.5}}{1 - e^{-1}} \\right) = 100 \\left( 1 - \\frac{1 - 0.606531}{1 - 0.367879} \\right) = 100 \\left( 1 - \\frac{0.393469}{0.632121} \\right) \\approx 100(1 - 0.6225) = 37.75\\%$.\n\nFor $\\mu = 10$:\n$N = 100 \\left( 1 - \\frac{1 - e^{-5}}{1 - e^{-10}} \\right) = 100 \\left( 1 - \\frac{1 - 0.006738}{1 - 0.000045} \\right) = 100 \\left( 1 - \\frac{0.993262}{0.999955} \\right) \\approx 100(1 - 0.9933) = 0.67\\%$.\n\nThese calculations confirm that for a fixed level of neutralization $p$, the measured percent neutralization $N$ decreases as $\\mu$ increases. The assay's sensitivity and dynamic range are highest at low $\\mu$ and collapse at high $\\mu$.\n\nNow, we evaluate each option:\n\nA. This option correctly states the derived formula for $N$. It correctly identifies the low-$\\mu$ limit. Its numerical calculations ($49\\%$, $38\\%$, $0.67\\%$) are accurate roundings of my derived values ($48.75\\%$, $37.75\\%$, $0.67\\%$). Its conclusion that sensitivity collapses and that dynamic range is maximized at low-to-moderate $\\mu$ is fully supported by the analysis. This option is correct.\n\nB. This is incorrect. The relationship $N = 100p$ is an approximation valid only for $\\mu \\to 0$. Our derived formula for $N$ clearly shows a dependence on $\\mu$.\n\nC. This is incorrect. The analysis of the limits showed that sensitivity to $p$ (and thus dynamic range) is greatest at low $\\mu$ and collapses at high $\\mu$.\n\nD. This is incorrect. Our limit analysis for $\\mu \\to \\infty$ shows $N \\to 0$, not $100p$. Consequently, dynamic range collapses, it does not expand.",
            "answer": "$$\\boxed{A}$$"
        },
        {
            "introduction": "A well-designed assay must also be robust and reproducible. This practice introduces the Z'-factor, a widely used statistical metric in high-throughput screening (HTS) to quantify the quality of an assay by measuring the separation between positive and negative control signals. By calculating the Z'-factor from hypothetical control well data , you will learn how to connect the concepts of dynamic range and data variability into a single, powerful indicator of assay performance.",
            "id": "5091351",
            "problem": "A neutralization assay for an enveloped virus uses a luciferase reporter to quantify infection in a microplate format, producing Relative Luminescence Units (RLU). In each plate, dedicated control wells are included to bound the assay window: negative controls are virus-only wells with no neutralizing antibody, yielding high signal, and positive controls are wells with a potent neutralizing monoclonal antibody, yielding low signal. Assume that control well readouts are independent samples drawn from approximately normal (Gaussian) distributions and that robustness in High-Throughput Screening (HTS) is governed by the separation of the control distributions relative to their standard deviations.\n\nYou are provided the following raw RLU measurements for $6$ replicate control wells collected on the same plate:\n\n- Negative control ($n = 6$): $100300$, $99600$, $101500$, $100900$, $98900$, $100200$.\n- Positive control ($n = 6$): $9300$, $9800$, $8700$, $9100$, $9400$, $8900$.\n\nStarting from the definition of distribution separation in normal populations, where a robustness margin is established by non-overlap of the $k$-standard-deviation intervals around each mean, derive the dimensionless statistic used in HTS to quantify assay quality based on the dynamic range adjusted by variability, using $k = 3$ as the conventional choice for tail coverage. Compute this statistic from the data above by first determining the unbiased sample means and unbiased sample standard deviations for each control group and then evaluating the derived expression.\n\nExpress the final value as a decimal and round your answer to four significant figures.",
            "solution": "The problem asks for the derivation and calculation of a dimensionless statistic that quantifies assay quality, known in HTS as the Z'-factor. Its derivation begins with the concept of separating the signal distributions of the positive and negative controls.\n\nLet the negative control (NC) population be described by a normal distribution with mean $\\mu_{NC}$ and standard deviation $\\sigma_{NC}$, and the positive control (PC) population by a normal distribution with mean $\\mu_{PC}$ and standard deviation $\\sigma_{PC}$. The problem specifies $\\mu_{NC} > \\mu_{PC}$.\n\nAssay robustness is defined by the non-overlap of the $k$-standard-deviation intervals around each mean. The point where the intervals just touch is given by $\\mu_{NC} - k\\sigma_{NC} = \\mu_{PC} + k\\sigma_{PC}$, which rearranges to $\\mu_{NC} - \\mu_{PC} = k(\\sigma_{NC} + \\sigma_{PC})$. This states that the difference in means must be at least $k$ times the sum of the standard deviations for the distributions to be considered separate.\n\nThe Z'-factor is defined as $1$ minus the ratio of the combined variability to the dynamic range. Using the conventional choice of $k=3$:\n$$ Z' = 1 - \\frac{3(\\sigma_{NC} + \\sigma_{PC})}{|\\mu_{NC} - \\mu_{PC}|} $$\nSince the true population parameters are unknown, we estimate them using the unbiased sample mean ($\\bar{x}$) and unbiased sample standard deviation ($s$):\n$$ \\bar{x} = \\frac{1}{n}\\sum_{i=1}^{n} x_i \\quad \\text{and} \\quad s = \\sqrt{\\frac{1}{n-1}\\sum_{i=1}^{n} (x_i - \\bar{x})^2} $$\nwhere $n$ is the number of replicates in the sample.\n\nFirst, we calculate these statistics for the negative control (NC) group: $x_{NC} = \\{100300, 99600, 101500, 100900, 98900, 100200\\}$.\nThe sample mean is $\\bar{x}_{NC} \\approx 100233.33$.\nThe unbiased sample standard deviation is $s_{NC} \\approx 920.14492$.\n\nNext, we calculate the statistics for the positive control (PC) group: $x_{PC} = \\{9300, 9800, 8700, 9100, 9400, 8900\\}$.\nThe sample mean is $\\bar{x}_{PC} = 9200$.\nThe unbiased sample standard deviation is $s_{PC} \\approx 389.87177$.\n\nFinally, we compute the Z'-factor using the sample statistics:\n$$ Z' = 1 - \\frac{3(s_{NC} + s_{PC})}{|\\bar{x}_{NC} - \\bar{x}_{PC}|} $$\nSubstituting the calculated values:\n$$ Z' = 1 - \\frac{3(920.14492 + 389.87177)}{|100233.33 - 9200|} $$\n$$ Z' = 1 - \\frac{3(1310.01669)}{91033.33} $$\n$$ Z' = 1 - \\frac{3930.05007}{91033.33} $$\n$$ Z' \\approx 1 - 0.0431713 \\approx 0.9568287 $$\nRounding the answer to four significant figures gives $0.9568$. A Z'-factor between $0.5$ and $1.0$ is considered indicative of an excellent assay.",
            "answer": "$$\n\\boxed{0.9568}\n$$"
        },
        {
            "introduction": "The final step in many neutralization experiments is to analyze the data to determine a quantitative measure of potency, such as the 50% neutralization titer ($NT_{50}$). This exercise provides a hands-on approach to calculating this critical value from a typical serial dilution dataset. Following the steps in this problem , you will practice using linear interpolation on a semilog plot and learn how to propagate measurement uncertainty to construct a confidence interval for your final titer.",
            "id": "5091328",
            "problem": "A laboratory evaluates a serum sample in a virus neutralization assay using serial 3-fold dilutions (1:40, 1:120, 1:360, 1:1080, 1:3240). For each dilution, percent neutralization is measured in 3 independent replicate wells. The measured values (percent neutralization) are:\n- 1:40: 93%, 95%, 96%\n- 1:120: 82%, 79%, 85%\n- 1:360: 61%, 58%, 63%\n- 1:1080: 42%, 45%, 39%\n- 1:3240: 18%, 20%, 16%\n\nBy definition, the neutralization titer at 50% (NT50) is the reciprocal dilution that yields 50% neutralization. Consider a semilog plot with the $x$-axis as $\\log_{10}$(reciprocal dilution) and the $y$-axis as percent neutralization. Assume:\n- Near the midpoint, the neutralization-versus-$\\log_{10}$(dilution) relationship is locally linear between the two dilutions that bracket 50%.\n- Measurement errors across replicates at each dilution are independent, approximately normal, and characterized by the empirical standard error of the mean at that dilution.\n- You will interpolate NT50 using only the two bracketing dilutions’ replicate means on the semilog $x$-axis and quantify uncertainty via first-order error propagation to obtain a 95% confidence interval on the $\\log_{10}$ scale, then transform back to dilution.\n\nWhich option best specifies a correct procedure under these assumptions and reports the corresponding NT50 point estimate and 95% confidence interval?\n\nA. Interpolate linearly on the semilog plot between 1:360 and 1:1080 using their replicate means to estimate NT50, then propagate the replicate standard errors at those two dilutions via first-order error propagation on the $\\log_{10}$ scale and back-transform. This yields NT50 $\\approx 6.7\\times 10^{2}$ with a 95% confidence interval of approximately $[5.9\\times 10^{2},\\,7.7\\times 10^{2}]$.\n\nB. Interpolate linearly on the arithmetic dilution axis between 1:360 and 1:1080 using their replicate means to estimate NT50, then compute a symmetric 95% confidence interval in dilution space by standard error propagation. This yields NT50 $\\approx 7.7\\times 10^{2}$ with a 95% confidence interval of approximately $[7.0\\times 10^{2},\\,8.4\\times 10^{2}]$.\n\nC. Fit a four-parameter logistic to all dilution means and derive NT50 from the fitted curve; quantify uncertainty by plugging the mean squared error of the fit into the NT50 formula. This yields NT50 $\\approx 6.7\\times 10^{2}$ with a 95% confidence interval of approximately $[6.5\\times 10^{2},\\,6.9\\times 10^{2}]$.\n\nD. For each replicate, interpolate NT50 on the semilog plot between 1:360 and 1:1080 using that replicate’s two points, then average the three replicate NT50 values and compute a $t$-based 95% confidence interval across replicates. This yields NT50 $\\approx 6.8\\times 10^{2}$ with a 95% confidence interval of approximately $[6.13\\times 10^{2},\\,7.47\\times 10^{2}]$.",
            "solution": "First, we calculate the mean percent neutralization for the dilutions bracketing the 50% target. The mean for the 1:360 dilution is $\\bar{y}_1 = (61 + 58 + 63)/3 \\approx 60.67\\%$. The mean for the 1:1080 dilution is $\\bar{y}_2 = (42 + 45 + 39)/3 = 42.00\\%$. These two points bracket the 50% neutralization level.\n\nThe interpolation is performed in semilog space where the coordinates are $(x, y) = (\\log_{10}(\\text{reciprocal dilution}), \\text{percent neutralization})$. The two bracketing points are $P_1 = (\\log_{10}(360), 60.67\\%)$ and $P_2 = (\\log_{10}(1080), 42.00\\%)$. Using linear interpolation to find the x-coordinate ($x_{50}$) corresponding to $y=50\\%$ neutralization:\n$$ x_{50} = x_1 + (y_{\\text{target}} - \\bar{y}_1) \\frac{x_2 - x_1}{\\bar{y}_2 - \\bar{y}_1} $$\n$$ x_{50} = \\log_{10}(360) + (50 - 60.67) \\frac{\\log_{10}(1080) - \\log_{10}(360)}{42.00 - 60.67} \\approx 2.5563 + (-10.67) \\frac{0.4771}{-18.67} \\approx 2.8289 $$\nThe NT50 is the anti-log of this value: $\\text{NT50} = 10^{2.8289} \\approx 674.4$. This point estimate is approximately $6.7 \\times 10^2$.\n\nTo quantify the uncertainty, we use first-order error propagation. The variance of $x_{50}$ depends on the variances of the mean neutralization values, $\\bar{y}_1$ and $\\bar{y}_2$. The standard errors of the mean (SEM) are calculated from the replicate data. For the 1:360 dilution, the sample variance is $s_1^2 = 19/3$, so the squared SEM is $\\sigma^2_{\\bar{y}_1} = s_1^2 / 3 = 19/9$. For the 1:1080 dilution, the sample variance is $s_2^2 = 9$, so the squared SEM is $\\sigma^2_{\\bar{y}_2} = s_2^2 / 3 = 3$.\n\nThe variance of $x_{50}$ is given by:\n$$ \\sigma^2_{x_{50}} \\approx \\left(\\frac{\\partial x_{50}}{\\partial \\bar{y}_1}\\right)^2 \\sigma^2_{\\bar{y}_1} + \\left(\\frac{\\partial x_{50}}{\\partial \\bar{y}_2}\\right)^2 \\sigma^2_{\\bar{y}_2} $$\nAfter computing the partial derivatives and substituting the values, we find the standard error of $x_{50}$ to be $\\sigma_{x_{50}} \\approx 0.0299$.\n\nThe 95% confidence interval for $x_{50}$ is $x_{50} \\pm 1.96 \\cdot \\sigma_{x_{50}}$, which is $2.8289 \\pm 1.96 \\cdot 0.0299 \\approx 2.8289 \\pm 0.0586$. This gives the interval $[2.7703, 2.8875]$ in $\\log_{10}$ space.\nTransforming this interval back to the dilution scale gives the 95% CI for the NT50:\n- Lower bound: $10^{2.7703} \\approx 589.3$\n- Upper bound: $10^{2.8875} \\approx 771.8$\nThe resulting 95% CI is approximately $[5.9 \\times 10^2, 7.7 \\times 10^2]$.\n\nThe procedure described in option A and the resulting values match this derivation.",
            "answer": "$$\\boxed{A}$$"
        }
    ]
}